Generate Biomedicines, Inc. - GENB
Sector:
Healthcare
· Industry:
Biotechnology
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
Value (USD)
Total reported value ($000)
$1.154B
QoQ value delta ($000)
—
Shares
Total shares
92,524,967
QoQ shares delta
—
Total shares held by funds (by quarter)
Market chart (GENB)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Flagship Pioneering, LLC | 783,413 | 62,673,117 | 67.44% |
| FMR LLC | 52,719 | 4,217,524 | 0.0% |
| Capital World Investors | 50,051 | 4,004,149 | 0.01% |
| BRAIDWELL LP | 44,912 | 3,592,999 | 1.5% |
| JPMORGAN CHASE & CO | 33,922 | 2,947,259 | 0.0% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 26,371 | 2,109,633 | 0.0% |
| ARCH Venture Management, LLC | 24,305 | 1,944,426 | 3.59% |
| HARBOURVEST PARTNERS LLC | 21,527 | 1,722,210 | 21.33% |
| BAKER BROS. ADVISORS LP | 17,795 | 1,423,602 | 0.1% |
| HARVARD MANAGEMENT CO INC | 13,888 | 1,111,100 | 0.76% |
| NVIDIA CORP | 10,416 | 833,325 | 0.06% |
| Siren, L.L.C. | 9,201 | 736,104 | 0.26% |
| Davern Capital Partners, LP | 7,397 | 591,800 | 2.03% |
| Alyeska Investment Group, L.P. | 6,250 | 500,000 | 0.02% |
| ARK Investment Management LLC | 6,230 | 498,408 | 0.05% |
| MILLENNIUM MANAGEMENT LLC | 4,711 | 376,893 | 0.0% |
| UBS Group AG | 4,458 | 356,704 | 0.0% |
| Affinity Asset Advisors, LLC | 4,375 | 350,000 | 0.23% |
| MORGAN STANLEY | 4,216 | 337,302 | 0.0% |
| CenterBook Partners LP | 3,335 | 266,813 | 0.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,312 | 185,000 | 0.37% |
| GOLDMAN SACHS GROUP INC | 2,133 | 170,695 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,641 | 131,319 | 0.0% |
| SEVEN GRAND MANAGERS, LLC | 1,562 | 125,000 | 0.1% |
| JANE STREET GROUP, LLC | 1,542 | 123,371 | 0.0% |